期刊文献+

黄芪甲苷对糖尿病肾病大鼠肾脏的保护作用及其机制 被引量:53

Protective effect of astragaloside IV on kidney of diabetic nephropathy rats
下载PDF
导出
摘要 目的:观察黄芪甲苷(AS-IV)对糖尿病肾病(DN)肾脏的保护作用及其机制。方法:38只清洁级雄性SD大鼠分成正常组(10只)、模型组(14只)和AS-IV干预组(14只),用链脲佐菌素造模,成功后1周开始治疗,期间每4周动态观测血糖及尿微量白蛋白,治疗12周后处死大鼠取材及采血,取肾皮质行HE和Masson染色观察,并检测β1整合素、整合素连接激酶(ILK)和α-actinin-4的蛋白表达水平。结果:干预8周末AS-IV组血糖水平较模型组明显降低(P<0.01)。干预12周末AS-IV组与模型组相比,尿微量白蛋白明显下降(P<0.01),并使因造模引起的β1整合素、ILK和α-actinin-4表达水平的变化产生逆变(P<0.05)。与正常组比较,模型组的β1整合素、ILK和α-actinin-4表达水平均有明显差异(P<0.05)。结论:AS-IV对DN肾脏有明显保护作用,能降低血糖和尿白蛋白排泄量,改善足细胞黏附功能,从而延缓DN的进展。 AIM: To observe the protective effect of astragaloside IV (AS-IV) on the kidney of diabetic ne- phropathy (DN) rats and its mechanism. METHODS: Male SD rats (n = 38) were divided into normal group (n = 10), model group (n = 14) and AS-IV intervention group (n = 14). The rats in model group and intervention group were injec- ted with streptozotocin for inducing DN. One week after the success of modeling, the blood glucose and urinary microalbu- min were dynamically monitored every 4 weeks during the study. After treatment for 12 weeks, the rats were sacrificed, the blood samples and the renal cortex were collected. HE staining and Masson staining were applied for observing the patho- logical changes of the renal tissues. The protein levels of β1 integrin, integrin-linked kinase (ILK) and α-actinin-4 were also detected. RESULTS : At the end of the 8th week, the glucose level in AS-IV intervention group was significantly low- er than that in model group (P 〈0.01). After 12 weeks of treatment, compared with model group, the amount of urinary microalbumin in AS-IV intervention group was significantly decreased (P 〈 0.01 ), and the inverse changes of the β1 inte- grin, ILK and α-actinin-4 expression in AS-IV intervention group were also observed ( P 〈 0.05 ). Compared with normal group, the levels of β1 integrin, ILK and α-actinin-4 in model group were significantly different (P 〈 0.05 ). CONCLU- SION: AS-IV has a protective effect on DN kidneys. AS-IV reduces blood glucose and urinary albumin excretion, improves the adhesion of podocytes and delays the development of DN.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2014年第2期351-354,共4页 Chinese Journal of Pathophysiology
基金 深圳市科技研发资金资助项目(No.JCYJ20120830163410835 No.JCYJ20130402092657779)
关键词 黄芪甲苷 糖尿病肾病 足细胞 蛋白尿 Astragaloside IV Diabetic nephropathies Podocytes Proteinuria
  • 相关文献

参考文献9

  • 1Weil EJ, Lemley KV, Mason CC, et al. Podocyte detach-ment and reduced glomerular capillary endothelial fenestra-tion promote kidney disease in type 2 diabetic nephropathy[J]. Kidney Int, 2012, 82(9) : 1010-1017.
  • 2Reidy K, Susztak K. Epithelial-mesenchymal transitionand podocyte loss in diabetic kidney disease [ J]. Am JKidney Dis, 2009,54(4) : 590- 593.
  • 3Teiken JM, Audettey JL, Laturnus DI, et al. Podocyteloss in aging OVE26 diabetic mice[ J]. Anat Rec ( Hobo-ken) ,2008,291(1) : 114-121.
  • 4Toyoda M, Najafian B, Kim Y,et al. Podocyte detach-ment and reduced glomerular capillary endothelial fenestra-tion in human type 1 diabetic nephropathy [ J]. Diabetes,2007,56(8) : 2155-2160.
  • 5Zhang M, Liu M, Xiong M, et al. Schisandra chinensisfruit extract attenuates albuminuria and protects podocyteintegrity in a mouse model of streptozotocin-induced dia-betic nephropathy [ J]. J Ethnopharmacol, 2012,141(1): 111-118.
  • 6Wolf G, Ziyadeh FN. Molecular mechanisms of diabeticrenal hypertrophy [ J]. Kidney Int, 1999, 56(2): 393-405.
  • 7Fukuda A, Chowdhury MA, Venkatareddy MP, et al.Growth-dependent podocyte failure causes glomerulosclero-sis[ J]. J Am Soc Nephrol, 2012, 23(8) : 1351-1363.
  • 8马莲顺,肖植涛,叶杰成,刘梅,郑广娟,李楚天,陆伟标,陈德臻,杨海峰,朱林燕.黄芪甲苷拮抗马兜铃酸Ⅰ所致的急性肾小管损伤[J].中国病理生理杂志,2012,28(11):1966-1970. 被引量:17
  • 9李志杰,张悦,刘煜敏,陆海英,李亚丽,张燕.黄芪多糖对早期糖尿病肾病大鼠足细胞nephrin和podocin表达的影响[J].中国病理生理杂志,2011,27(9):1772-1776. 被引量:90

二级参考文献27

  • 1乔洪翔,李连达,吴理茂.马兜铃酸细胞分子毒理学研究进展[J].中国药理学与毒理学杂志,2006,20(6):515-520. 被引量:10
  • 2曹闻,张莹雯.黄芪多糖冲剂治疗糖尿病肾病的临床观察[J].湖北中医杂志,2007,29(4):12-13. 被引量:12
  • 3赵学兰,林松娟,张琳琳,王金玲.黄芪当归合剂治疗糖尿病肾病的临床观察[J].中成药,2007,29(5):641-644. 被引量:16
  • 4张东成,杨广珍.肾康注射液治疗慢性马兜铃酸肾病36例分析[J].中国误诊学杂志,2007,7(6):1302-1303. 被引量:3
  • 5Akhtar M,AlMana H.Molecular basis of proteinuria[J].Adv Anat Pathol,2004,11(6):304-309.
  • 6White KE,Bilous RW,Diabiopsies Study Group.Structural alterations to the podocyte are related to proteinuria in type 2 diabetic patients[J].Nephrol Dial Transplant,2004,19(6):1437-1440.
  • 7Wolf G,Chen S,Ziyadeh FN,et al.From the periphery of glomerular capillary wall toward the center of disease:podocyte injury comes of age in diabetic nephropathy[J].Diabetes,2005,54(6):1626-1630.
  • 8Toyoda M,Suzuki D,Umezono T,et al.Expression of human nephrin mRNA in diabetic nephropathy[J].Nephrol Dial Transplant,2004,19(2):380-385.
  • 9Barutta F,Corbelli A,Mastrocola R,et al.Cannabinoid receptor 1 blockade ameliorates albuminuria in experimental diabetic nephropathy[J].Diabetes,2010,59(4):1046-1054.
  • 10Doublier S,Salvidio G,Lupia E,et al.Nephrin expression is reduced in human diabetic nephropathy:evidence for a distinct role for glycated albumin and angiotensin II[J].Diabetes,2003,52(4):1023-1030.

共引文献101

同被引文献761

引证文献53

二级引证文献508

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部